טוען...
Reducing the use of inhaled corticosteroids in mild-moderate COPD: an observational study in east London
Inhaled corticosteroids (ICS) are often prescribed for worsening breathlessness, exacerbation frequency or lung function in chronic obstructive pulmonary disease (COPD). In mild-moderate disease and infrequent exacerbations, treatment risks may outweigh benefits and ICS may be withdrawn safely under...
שמור ב:
| הוצא לאור ב: | NPJ Prim Care Respir Med |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group UK
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395712/ https://ncbi.nlm.nih.gov/pubmed/32737296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41533-020-00191-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|